Document is current
Any future updates will be listed below
-
Authors
Mesquida, Jaume https://orcid.org/0000-0003-3670-5021
Caballer, A.
Cortese, L.
Vila, C.
Karadeniz, U.
Pagliazzi, M.
Zanoletti, M.
Pacheco, A. Pérez
Castro, P.
García-de-Acilu, M.
Mesquita, R. C.
Busch, D. R.
Durduran, T.
,
Durduran, Turgut
Pagliazzi, Marco
Cortese, Lorenzo
Zanoletti, Marta
Karadeniz, Umut
Mesquida, Jaume https://orcid.org/0000-0003-3670-5021
Caballer, Alba
Nogales, Sara
Espinal, Cristina
Gruartmoner, Guillem
Terán, Puri Pérez
Vilà, Clara
Picazo, Lucía
Ferrer, Ricard
De Acilu, Marina García
Chiscano, Luis
Mera, Abraham
Castro, Pedro
Téllez, Adrián
Fernández, Sara
Matas, Ana
Fuentes, Fernando
Serra, Isabel
Romero, David
Font, Francesc
Myers, Tim
Busch, David R.
Dave, Siddharth
Cheruku, Sreekanth
Choi, Christopher
Lahsaei, Peiman
Olson, DaiWai
Pacheco, Argelia Pérez
Quispe Siccha, Rosa María
Liceaga, Eduardo
De Oca Hernández, Félix Jerandy Monte
Besen, Bruno Adler Maccagnan Pinheiro
Taniguchi, Leandro Utino
Mendes, Pedro Vitale
Mesquita, Rickson Coelho
Soto, Andrés Fabián Quiroga
Aventurato, Italo Karmann
de Oliveira, Laís Bacchin
Delazari, Lilian Elisabete Bernardes
dos Santos, Lígia
Ratti, Roceto
Falcão, Antonio Luis Eiras
Marin-Corral, Judith
Serrano-Loyola, Raúl
Carbajal-Robles, Verónica
Santillan-Aguayo, Enrique
Parada-Guzmán, Melvin
Menezes-Forti, Rodrigo
Bacchin, Luis
Lívio-Emidio, Gabriela
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04689477 at ClinicalTrials.govDocuments that mention this clinical trial
Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units
https://doi.org/10.1186/s13054-021-03803-2
-
Funding
Funding for this research was provided by:
fundación cellex
generalitat de catalunya
european comission horizon 2020
fundació mir-puig
agencia estatal de investigación
severo ochoa programme for centers of excellence in r&d
“la caixa” foundation
- License Information
-
More Information
Article History
Received: 29 July 2021
Accepted: 25 October 2021
First Online: 8 November 2021
Declarations
:
: Ethical approval for this study was provided initially by the Comitè d’Ètica i Investigació amb Medicaments of the Institut d’Investigació i Innovació Parc Taulí (I3PT) on 7 May 2020 (Ref 2020/579), and subsequently approved by each center's IRB. Informed consent was obtained according to the IRB guidelines.
: Not applicable.
: The authors declare that they have no competing interests.
